In jeff Wallin`s own words---

``This accord represents an important milestone for our company,`` said Jeff Wallin, president and CEO of Patriot Scientific. ``This agreement replaces costly ongoing litigation with a win-win scenario that supports our efforts to license and protect our company`s intellectual property on a broader scale. The TPL Group is well-positioned to aggressively license these core technology patents, freeing Patriot Scientific to focus on our equally innovative IGNITE and INFLAME array microprocessor core technologies, as well as other innovations currently in our development pipeline.`` ads